---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003236"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T21:26:09.048863+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints Elizabeth Taylor as CFO, McNeil as Chief Accounting Officer & CAO

## Summary
- Elizabeth Taylor appointed CFO effective Jan 15, 2025; base salary $250,000, eligible for annual restricted stock award up to 75% of salary and cash bonus up to 75% of salary.
- Michael McNeil assumes roles of Chief Accounting Officer and Chief Administrative Officer; base salary increased to $234,000, bonus eligibility raised to up to 75% of salary.
- Taylor joins from Imbed Biosciences where she served as CFO; holds MBA from Harvard and BA from Princeton.
- Both executive employment agreements include severance provisions: one year base salary, accelerated stock vesting, and COBRA reimbursement upon qualifying termination.

## SEC filing metadata
- accession: 0001493152-25-003236
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/0001493152-25-003236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003236
- JSON: https://secwatch.observer/filing/0001493152-25-003236.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003236.txt

## Key facts
- Executive change
  Elizabeth B. Taylor was appointed as Chief Financial Officer at Sanara MedTech Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On January 15, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Elizabeth B. Taylor to serve as the Chief Financial Officer of the Company, including the role of principal financial officer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/0001493152-25-003236-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.